OQS
ETNB

Occudo Quantitative Strategies’s 89bio ETNB Stock Holding History

Occudo Quantitative Strategies’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,126
Closed -$232K – 1090
2022
Q3 		$232K Buy
40,126
+13,459
+50% +$59.1K 0.02% 928
2022
Q2 		$86K Buy
26,667
+10,234
+62% +$30.9K 0.01% 1030
2022
Q1 		$62K Buy
+16,433
New +$106K 0.01% 1061

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Occudo Quantitative Strategies's ETNB Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of 89bio (ETNB) in Q4 2022, closing a stake of 40,126 shares — an estimated $232K sold.

Occudo Quantitative Strategies first reported a position in ETNB in Q1 2022 and held it in 3 quarters. The position peaked at $232K in Q3 2022. 106 funds tracked by Wall St. Rank hold ETNB as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining 89bio position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 40,126 89bio shares in Q4 2022, an estimated $232K.
  • Occudo Quantitative Strategies first reported a position in 89bio in Q1 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's 89bio position peaked at $232K in Q3 2022.
  • 106 funds tracked by Wall St. Rank held 89bio as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.